IL17A and ankylosing spondylitis: Ankylosing spondylitis [36] is characterized by the higher release of NETs from polymorphonuclear leukocytes containing bioactive IL-17A and IL-1β, which can in turn mediate the osteogenic differentiation of MSCs into bone-forming cells.